Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement impacts and potential disruption to hospital operations, with 61% expect | If potential reimbursement cuts exceed 10%, respondents say it will have negative impacts on staffing decisions and technological investments.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Patient collections are playing a bigger and bigger role in health systems’ total revenues, bringing a new focus on the…

Just hours after the Trump administration announced action against fraud in the hospice and home health spaces, Vice President JD…

Even without counting the multi-billion hit tied to the early termination of a major joint venture and outsourcing arrangement,…

There’s a thing that happens in American healthcare.You've got these massive systems—pharma conglomerates, hospital networks,…

Hospital-based shootings across the U.S. | Between 2000 and 2024, hospital-based shootings increased from six to 34 per year—or a…

Nearly 80% of payers now prefer implementing vendor-built artificial intelligence tools rather than developing internal…